Insights into the glioblastoma tumor microenvironment: current and emerging therapeutic approaches
Glioblastoma (GB) is an intrusive and recurrent primary brain tumor with low survivability. The heterogeneity of the tumor microenvironment plays a crucial role in the stemness and proliferation of GB. The tumor microenvironment induces tumor heterogeneity of cancer cells by facilitating clonal evol...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-03-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1355242/full |
| _version_ | 1797269062667993088 |
|---|---|
| author | Dev Kumar Tripathy Lakshmi Priya Panda Suryanarayan Biswal Kalpana Barhwal |
| author_facet | Dev Kumar Tripathy Lakshmi Priya Panda Suryanarayan Biswal Kalpana Barhwal |
| author_sort | Dev Kumar Tripathy |
| collection | DOAJ |
| description | Glioblastoma (GB) is an intrusive and recurrent primary brain tumor with low survivability. The heterogeneity of the tumor microenvironment plays a crucial role in the stemness and proliferation of GB. The tumor microenvironment induces tumor heterogeneity of cancer cells by facilitating clonal evolution and promoting multidrug resistance, leading to cancer cell progression and metastasis. It also plays an important role in angiogenesis to nourish the hypoxic tumor environment. There is a strong interaction of neoplastic cells with their surrounding microenvironment that comprise several immune and non-immune cellular components. The tumor microenvironment is a complex network of immune components like microglia, macrophages, T cells, B cells, natural killer (NK) cells, dendritic cells and myeloid-derived suppressor cells, and non-immune components such as extracellular matrix, endothelial cells, astrocytes and neurons. The prognosis of GB is thus challenging, making it a difficult target for therapeutic interventions. The current therapeutic approaches target these regulators of tumor micro-environment through both generalized and personalized approaches. The review provides a summary of important milestones in GB research, factors regulating tumor microenvironment and promoting angiogenesis and potential therapeutic agents widely used for the treatment of GB patients. |
| first_indexed | 2024-04-25T01:42:24Z |
| format | Article |
| id | doaj.art-ac64171a6dd848d19a68787339d6c327 |
| institution | Directory Open Access Journal |
| issn | 1663-9812 |
| language | English |
| last_indexed | 2024-04-25T01:42:24Z |
| publishDate | 2024-03-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Pharmacology |
| spelling | doaj.art-ac64171a6dd848d19a68787339d6c3272024-03-08T04:33:42ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122024-03-011510.3389/fphar.2024.13552421355242Insights into the glioblastoma tumor microenvironment: current and emerging therapeutic approachesDev Kumar Tripathy0Lakshmi Priya Panda1Suryanarayan Biswal2Kalpana Barhwal3Department of Physiology, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, IndiaDepartment of Physiology, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, IndiaDepartment of Human Genetics and Molecular Medicine, Central University of Punjab, Bathinda, IndiaDepartment of Physiology, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, IndiaGlioblastoma (GB) is an intrusive and recurrent primary brain tumor with low survivability. The heterogeneity of the tumor microenvironment plays a crucial role in the stemness and proliferation of GB. The tumor microenvironment induces tumor heterogeneity of cancer cells by facilitating clonal evolution and promoting multidrug resistance, leading to cancer cell progression and metastasis. It also plays an important role in angiogenesis to nourish the hypoxic tumor environment. There is a strong interaction of neoplastic cells with their surrounding microenvironment that comprise several immune and non-immune cellular components. The tumor microenvironment is a complex network of immune components like microglia, macrophages, T cells, B cells, natural killer (NK) cells, dendritic cells and myeloid-derived suppressor cells, and non-immune components such as extracellular matrix, endothelial cells, astrocytes and neurons. The prognosis of GB is thus challenging, making it a difficult target for therapeutic interventions. The current therapeutic approaches target these regulators of tumor micro-environment through both generalized and personalized approaches. The review provides a summary of important milestones in GB research, factors regulating tumor microenvironment and promoting angiogenesis and potential therapeutic agents widely used for the treatment of GB patients.https://www.frontiersin.org/articles/10.3389/fphar.2024.1355242/fullglioblastomatumor microenvironmentangiogenesisimmunotherapyblood-brain barriertherapeutic approaches |
| spellingShingle | Dev Kumar Tripathy Lakshmi Priya Panda Suryanarayan Biswal Kalpana Barhwal Insights into the glioblastoma tumor microenvironment: current and emerging therapeutic approaches Frontiers in Pharmacology glioblastoma tumor microenvironment angiogenesis immunotherapy blood-brain barrier therapeutic approaches |
| title | Insights into the glioblastoma tumor microenvironment: current and emerging therapeutic approaches |
| title_full | Insights into the glioblastoma tumor microenvironment: current and emerging therapeutic approaches |
| title_fullStr | Insights into the glioblastoma tumor microenvironment: current and emerging therapeutic approaches |
| title_full_unstemmed | Insights into the glioblastoma tumor microenvironment: current and emerging therapeutic approaches |
| title_short | Insights into the glioblastoma tumor microenvironment: current and emerging therapeutic approaches |
| title_sort | insights into the glioblastoma tumor microenvironment current and emerging therapeutic approaches |
| topic | glioblastoma tumor microenvironment angiogenesis immunotherapy blood-brain barrier therapeutic approaches |
| url | https://www.frontiersin.org/articles/10.3389/fphar.2024.1355242/full |
| work_keys_str_mv | AT devkumartripathy insightsintotheglioblastomatumormicroenvironmentcurrentandemergingtherapeuticapproaches AT lakshmipriyapanda insightsintotheglioblastomatumormicroenvironmentcurrentandemergingtherapeuticapproaches AT suryanarayanbiswal insightsintotheglioblastomatumormicroenvironmentcurrentandemergingtherapeuticapproaches AT kalpanabarhwal insightsintotheglioblastomatumormicroenvironmentcurrentandemergingtherapeuticapproaches |